First Midwest Bank Trust Division’s Regeneron Pharmaceuticals REGN Stock Holding History

First Midwest Bank Trust Division’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-511	Closed	-$247K	–	388
2020 Q4	$247K	Buy	+511	New	+$276K	0.04%	325
2016 Q1	–	Sell	-481	Closed	-$261K	–	421
2015 Q4	$261K	Sell	481 -10	-2%	-$5.42K	0.04%	317
2015 Q3	$229K	Sell	491 -280	-36%	-$150K	0.04%	354
2015 Q2	$393K	Buy	+771	New	+$376K	0.06%	278

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Midwest Bank Trust Division's REGN Position: Q1 2021 in Review

First Midwest Bank Trust Division sold out of Regeneron Pharmaceuticals (REGN) in Q1 2021, closing a stake of 511 shares — an estimated $247K sold.

First Midwest Bank Trust Division first reported a position in REGN in Q2 2015 and held it in 4 quarters. The position peaked at $393K in Q2 2015. 924 funds tracked by Wall St. Rank hold REGN as of Q1 2021.

First Midwest Bank Trust Division reported no remaining Regeneron Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
First Midwest Bank Trust Division sold 511 Regeneron Pharmaceuticals shares in Q1 2021, an estimated $247K.
First Midwest Bank Trust Division first reported a position in Regeneron Pharmaceuticals in Q2 2015 and held it in 4 quarters.
First Midwest Bank Trust Division's Regeneron Pharmaceuticals position peaked at $393K in Q2 2015.
924 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q1 2021, filed 15 Apr 2021.